基于身高的院前儿科急救药物剂量推荐装置(PaedER)的研发及联邦州范围前瞻性评估:预防最严重药物差错的简易工具
该研究开发了基于身高的儿科急救剂量推荐系统PaedER,因伦理委员会预期PaedER对结局有正面效应而否决随机化,故采用前后干预试验。干预前数据回顾性取自科隆急救服务两年电子记录与医疗方案,干预后数据在联邦州范围前瞻性开放试验中收集六年,记录静脉或骨髓腔内给予芬太尼、咪达唑仑、氯胺酮或肾上腺素的剂量。主要结局为基于体重的推荐剂量偏差(DRD)数量与严重程度。共分析干预前59次与干预后91次院前儿童给药,总体药物DRD>300%的发生率干预前为22.0%、干预后为2.2%(p<0.001);干预前所有肾上腺素给药均过量(DRD>300%),干预后无一例(p<0.001)。作者结论:使用PaedER使药物差错减少90%(95%CI 57%–98%,p<0.001),并预防了所有肾上腺素给药相关的潜在危及生命差错;亟需提高儿科急诊药物剂量安全性,简易身高系统可支持医疗提供者并帮助避免危及生命的药物差错。
要点
- 院前儿科急救中,使用PaedER身高剂量尺后总体药物DRD>300%的发生率从干预前22.0%降至干预后2.2%(p<0.001)。
- 干预前所有肾上腺素给药均出现DRD>300%的过量,干预后无一例(p<0.001)。
- PaedER使药物差错减少90%(95%CI 57%–98%,p<0.001)。
- 研究纳入院前静脉或骨髓腔内给予芬太尼、咪达唑仑、氯胺酮或肾上腺素的儿童给药记录,共干预前59次、干预后91次。
- 作者认为简易身高系统可支持医疗提供者并帮助避免危及生命的药物差错。
适用人群与场景
- 院前急救场景中需要静脉或骨髓腔内给予芬太尼、咪达唑仑、氯胺酮或肾上腺素的儿童。
诊断标准与关键阈值
- 药物剂量偏差(DRD)基于患者体重计算,DRD>300%定义为严重剂量偏差。
处置流程与药物剂量
- 使用PaedER(儿科急救身高剂量尺)根据身高推荐药物剂量,涉及药物为静脉或骨髓腔内芬太尼、咪达唑仑、氯胺酮或肾上腺素;原文未给出具体剂量数值。
研究设计与关键结果
- 研究类型为前后干预试验(pre-post interventional trial),因伦理委员会预期PaedER对结局有正面效应而否决随机化;干预前数据回顾性取自科隆急救服务两年电子记录与医疗方案,干预后数据在联邦州范围前瞻性开放试验中收集六年。
- 共分析干预前59次和干预后91次院前儿童给药。
- 总体药物DRD>300%发生率:干预前22.0% vs 干预后2.2%(p<0.001)。
- 肾上腺素给药DRD>300%:干预前所有给药均过量,干预后无一例(p<0.001)。
- 作者报告PaedER使药物差错减少90%(95%CI 57%–98%,p<0.001),并预防了所有肾上腺素给药相关的潜在危及生命差错。
证据类型、等级与局限
- 证据类型:前后干预试验(因伦理原因未随机化)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,简易身高系统(PaedER)可支持医疗提供者并帮助避免危及生命的药物差错;使用PaedER使药物差错减少90%(95%CI 57%–98%,p<0.001)并预防了所有肾上腺素给药相关的潜在危及生命差错。
- 作者指出亟需提高儿科急诊药物剂量安全性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Drug dosing errors pose a particular threat to children in prehospital emergency care. With the Pediatric emergency ruler (PaedER), we developed a simple height-based dose recommendation system and evaluated its effectiveness in a pre-post interventional trial as the Ethics Committee disapproved randomization due to the expected positive effect of the PaedER on outcome.
METHODS: Pre-interventional data were retrospectively retrieved from the electronic records and medical protocols of the Cologne Emergency Medical Service over a two-year period prior to the introduction of the PaedER. Post-interventional data were collected prospectively over a six-year period in a federal state-wide open trial. The administered doses of either intravenous or intraosseous fentanyl, midazolam, ketamine or epinephrine were recorded. Primary outcome measure was the number and severity of drug dose deviation from recommended dose (DRD) based on the patient's weight.
RESULTS: Fifty-nine pre-interventional and 91 post-interventional prehospital drug administrations in children were analyzed. The rate of DRD > 300% overall medications were 22.0% in the pre- and 2.2% in the post-interventional group (p < 0.001). All administrations of epinephrine occurred excessive (DRD > 300%) in pre-interventional and none in post-interventional patients (p < 0.001).
CONCLUSIONS: The use of the PaedER resulted in a 90% reduction of medication errors (95% CI: 57% to 98%; p < 0.001) and prevented all potentially life-threatening errors associated with epinephrine administration. There is an urgent need to increase the safety of emergency drug dosing in children during emergencies. A simple height-based system can support health care providers and helps to avoid life-threatening medication errors.
参考来源
- Kaufmann J, Roth B, Engelhardt T, et al. Development and Prospective Federal State-Wide Evaluation of a Device for Height-Based Dose Recommendations in Prehospital Pediatric Emergencies: A Simple Tool to Prevent Most Severe Drug Errors. Prehosp Emerg Care. 2016. PMID: 27925849. doi:10.1080/10903127.2016.1248257
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。